Skip to main content

and
  1. Article

    Open Access

    Co-administration of FVIII with IVIG reduces immune response to FVIII in hemophilia A mice

    Hemophilia A is an X-linked recessive congenital bleeding disorder. Exogenous infusion of FVIII is the treatment of choice, and the development of immunoglobulins against FVIII (inhibitors) remains the major c...

    Sajjad Afraz, Ivan Stevic, Davide Matino, Jian** Wen in Scientific Reports (2022)

  2. Article

    Open Access

    Systematic reviews of prognosis studies: a critical appraisal of five core clinical journals

    Prognosis research refers to the investigation of association between a baseline health state, patient characteristic and future outcomes. The findings of several prognostic studies can be summarized in system...

    Davide Matino, Chatree Chai-Adisaksopha in Diagnostic and Prognostic Research (2017)

  3. No Access

    Article

    Aryl hydrocarbon receptor control of a disease tolerance defence pathway

    Disease tolerance is the ability of the host to reduce the effect of infection on host fitness. Analysis of disease tolerance pathways could provide new approaches for treating infections and other inflammator...

    Alban Bessede, Marco Gargaro, Maria T. Pallotta, Davide Matino, Giuseppe Servillo in Nature (2014)

  4. Article

    Open Access

    High rate of spontaneous inhibitor clearance during the long term observation study of a single cohort of 524 haemophilia A patients not undergoing immunotolerance

    The natural history of inhibitors in patients with haemophilia A not undergoing immune tolerance induction (ITI) is largely unknown. A recent randomized controlled trial suggests that the higher the FVIII dose...

    Giuseppe Tagariello, Alfonso Iorio, Davide Matino in Journal of Hematology & Oncology (2013)